 |
|
|
| |
Efficacy and Safety of Switching to Dolutegravir
Plus Rilpivirine in Virologically Suppressed Older PLWH:
Pooled Week 148 Results From SWORD-1 and SWORD-2
|
| |
| |
Glasgow 2023 Oct 23-26
Manyu Prakash,1 Richard Grove,2 Brian Wynne,3 Jean van Wyk,1 Bryn Jones,1 Andrew Clark1
1ViiV Healthcare, Brentford, UK; 2GSK, Brentford, UK; 3ViiV Healthcare, Durham, NC, US
|
| |
|
|
|
|
|
